首页> Nanomedicine (London, England)> Retrospective comparisons of nanoparticle albumin-bound paclitaxel and docetaxel neoadjuvant regimens for breast cancer.

Retrospective comparisons of nanoparticle albumin-bound paclitaxel and docetaxel neoadjuvant regimens for breast cancer.

导出 LinkOut

翻译打印收藏纠错

第一作者： Yan,Li

第一单位： Department of Breast Disease, the First Affiliated Hospital of Nanjing Medical University, Nanjing 210000, PR China.

作者： Yan,Li ^[1] ; Xiang,Chen ^[2] ; Qiannan,Zhu ^[1] ; Rui,Chen ^[1] ; Lu,Xu ^[3] ; Shuo,Li ^[1] ; Xiaoqing,Shi ^[1] ; Haiping,Xu ^[1] ; Yinggang,Xu ^[1] ; Weiwei,Zhang ^[1] ; Xiaofeng,Huang ^[1] ; Xiaoming,Zha ^[4] ; Jue,Wang ^[4]

作者单位： Department of Breast Disease, the First Affiliated Hospital of Nanjing Medical University, Nanjing 210000, PR China. ^[1] Department of Thyroid and Mammary Gland Surgery, Yixing People's Hospital, Wuxi 214200, PR China. ^[2] Department of Clinical Nutrition, First Affiliated Hospital of Nanjing Medical University, Nanjing 210000, PR China. ^[3] Department of Breast Disease, the First Affiliated Hospital of Nanjing Medical University, Nanjing 210000, PR China.;Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing Medical University, Nanjing 210000, PR China. ^[4]

关键词 breast cancer docetaxel nanoparticle albumin-bound paclitaxel neoadjuvant systemic treatment pathological complete response

医学主题词抗肿瘤联合化疗方案(Antineoplastic Combined Chemotherapy Protocols);乳腺肿瘤(Breast Neoplasms);人类(Humans);纳米粒子(Nanoparticles);肿瘤辅助疗法(Neoadjuvant Therapy);回顾性研究(Retrospective Studies);治疗结果(Treatment Outcome)

DOI 10.2217/nnm-2020-0458

PMID 33502252

发布时间 2021-07-09

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交